Latest News and Press Releases

LAUPHEIM, Germany and MILFORD, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...

LAUPHEIM, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced the...

LAUPHEIM, Germany, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a...

Construction of a new buffer media facility in LaupheimLargest investment in the German site; project duration of approx. three yearsContinuous modernization, automation, and digitalization of the...

Largest expansion in company’s 150+-year history opensMajor client project already underway; new clients actively being onboarded LAUPHEIM, Germany and MILFORD, Mass., July 11, 2024 (GLOBE...

LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, May 28, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization...

LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, May 02, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization...

Company honored with highest award for Central Massachusetts regionNew state-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business later this year ...

Exceptional capabilities in guiding therapies from early-stage development through to market based on over 50 years of biotech experience LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United...

Senta Brandt promoted to global position of Head of TransformationGerrick Rodrigues promoted to Global Head of IT LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, Feb. 06, 2024 ...